Find the latest Novavax, Inc. (NVAX) stock quote, history, news and other vital information to help you with your stock trading and investing. The firm's vaccine candidates include ResVax and NanoFlu. ...Inovio Shares Have Been Hot in 2020 but Watch for a Volatile SeptemberTesting is in High Demand as Spread of Infection RemainsNovavax to Provide Canada with Millions of Vaccine DosesNovavax and Canada Reach Agreement in Principle to Acquire Novavax' COVID-19 VaccineNovavax and Canada Reach Agreement in Principle to Acquire Novavax' COVID-19 VaccineNovavax and Canada Reach Agreement in Principle to Acquire Novavax' COVID-19 VaccineHepcidin Market 2020-Latest Advancements and Industry Outlook | Daiichi Sankyo Co Ltd, Pieris Pharmaceuticals Inc, Protagonist Therapeutics Inc, Noxxon Pharma AGVaccines Delivery Market Increasing Demand with Leading Player, Comprehensive Analysis, Forecast 2026Medical Devices Become Widely Used as Healthcare Systems Look to Ease BurdenVaccines Market Size, Share 2020|Global Trends, Industry Share, Growth Drivers, Business Opportunities and Demand Forecast to 2023Novel Coronavirus (COVID-19) Drugs Market In-depth Analysis, Reviews and Study Report 2020-2026Thinking about buying stock in Novavax, Inc., Moderna Inc, D. R. Horton Inc, Best Buy, or Hewlett Packard Enterprise Co?Severe Acute Respiratory Syndrome(SARS) Therapeutics Market 2020 Analysis report with Cross-Channel, Opportunities, Upturn Growth by 2026Novavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 VaccineNovavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 VaccineNovavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 VaccineHuman Vaccine Adjuvants Market Study Report and In-depth Analysis 2020Vaccine Particulate Adjuvants Market Analysis and Global Outlook During 2020-2026Virus Like Particles Market Global Research and Competitive Insights 2020 It produces vaccine candidates to respond to both known and emerging disease threats by using the proprietary recombinant nanoparticle vaccine technology. Cases Rise 1.1%; Governors Form Pact on Tests: Virus UpdateNovavax’s 3,500% Surge on a Covid-19 Vaccine Faces First TestCalifornia Hospital Use Rises; N.J. Loses Ground: Virus UpdateNovavax Covid Vaccine Gets $1.6 Billion in U.S. FundingOverlooked Covid-19 Vaccine Runners Up Defended by Wall StreetTesting is in High Demand as Spread of Infection RemainsNovavax, Inc.: Novavax and Canada Reach Agreement in Principle to Acquire Novavax’ COVID-19 VaccineNovavax and Canada Reach Agreement in Principle to Acquire Novavax’ COVID-19 VaccineMedical Devices Become Widely Used as Healthcare Systems Look to Ease BurdenVaccines Market analysis highlights the Impact of COVID-19 (2020-2024) | Increasing Use of Adjuvants in Vaccines to boost theNovavax, Inc.: Novavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 VaccineNovavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 VaccineNovavax, Inc.: Novavax Initiates Efficacy Trial of COVID-19 Vaccine in South AfricaNovavax Initiates Efficacy Trial of COVID-19 Vaccine in South AfricaNovavax, Inc.: Novavax and UK Government Announce Collaboration and Purchase Agreement for Novavax’ COVID-19 VaccineCanada Buying Doses of Covid-19 Vaccine From Novavax, J&J20 Firstfield Road Under terms of the agreement, SK Bioscience will make the vaccine antigen component during the pandemic period. Here’s what you need to know about the impact of Covid-19 to navigate the markets today.Small-cap biotech CytoDyn has asked the FDA to grant its drug, Leronlimab, an emergency-use authorization to treat mild to moderate Covid-19 cases. Novavax said its development and supply agreement with the SK Bioscience will help it supply its vaccine to global markets, including South Korea. His short position just got ‘obliterated,’ but this Tesla bear isn’t giving up Novavax, Inc. is operates as a clinical-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. Novavax is scheduled to release their next quarterly earnings announcement on Wednesday, August 14th 2019. Individual investors are placing their bets on biotech companies pursuing coronavirus advances.